Alpine Lifescience Private Limited
About Alpine Lifescience Private Limited
Data last updated:
Alpine Lifescience Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2019PTC354342. Its GSTIN is 07AASCA6688F1Z2 (Delhi).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Madhulika Upendra Kumar Singh and Sita Kharya.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C – 57/X3 Ground Floor C – Block Dilshad Garden Shahdara Delhi, New Delhi, Delhi, India – 110095.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.61 Cr, a growth of 50% compared to the previous year. For the same year it recorded a net profit of ₹21.03 Lakh (net margin 13%) and EBITDA of ₹28.18 Lakh (EBITDA margin 17.5%).
The company is associated with 1 brand: Alpine Life Science.
Company details
Contact details
Alpine Lifescience Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 57/X3 Ground Floor C – Block Dilshad Garden Shahdara Delhi, New Delhi, Delhi, India – 110095
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Alpine Lifescience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Alpine Lifescience operates one associated brand: Alpine Life Science. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides integrated pharmaceutical development, manufacturing, and healthcare solutions worldwide. | alpinelifescience.com |
Business activity
The main business activity of Alpine Lifescience is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Alpine Lifescience Private Limited, buy the company report.
Financials of Alpine Lifescience Private Limited
FY 2024 filings availableAlpine Lifescience Private Limited reported revenue of ₹1.61 Cr (up 50% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28.18 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.5% | ||||
| Net Profit Margin | 13% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alpine Lifescience Private Limited, buy the company report.
Board of directors of Alpine Lifescience Private Limited
Alpine Lifescience has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhulika Upendra Kumar Singh | Director | 28 Aug 2019 | 7 Years 1 Months | Current |
| Sita Kharya Also directs: Arka-Span Lifecare International Private Limited | Director | 07 May 2021 | 5 Years 5 Months | Current |
| Arihant Surana Also directs: Hplus Healthcare Service LLP, Chimera Medicare India LLP, Optlife Healthcare Private Limited and 2 more | Director | 28 Oct 2021 | 4 Years 11 Months | Current |
Auditor
Alpine Lifescience Private Limited is audited by Rohit Suri & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rohit Suri & Associates | FY 2023 | 012259N |
Shareholding
The shareholding of Alpine Lifescience Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Alpine Lifescience Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Alpine Lifescience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alpine Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alpine Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AASCA6688F1Z2 | Delhi | Active | 01 May 2020 |
To see the full GST registrations and return filing status of Alpine Lifescience Private Limited, buy the company report.
Recent activity
Alpine Lifescience Private Limited has 6 board changes on record since 2019: 3 appointments and 3 cessations. The latest: Arihant Surana ceased to be Additional Director on 12 Nov 2021.
Frequently asked questions
Alpine Lifescience is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 August 2019 (7+ years old) and is registered under CIN U24230DL2019PTC354342.
Alpine Lifescience has 3 current directors:
- Madhulika Upendra Kumar Singh - Director
- Sita Kharya - Director
- Arihant Surana - Director
The latest financial statements of Alpine Lifescience on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Alpine Lifescience is 07AASCA6688F1Z2, registered in Delhi.
The CIN (Corporate Identification Number) of Alpine Lifescience is U24230DL2019PTC354342. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alpine Lifescience was incorporated on 28 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Arihant Surana ceased to be Additional Director on 12 Nov 2021. Sita Kharya ceased to be Director Appointed In Casual Vacancy on 12 Nov 2021. Arihant Surana was appointed as Director on 28 Oct 2021. Alpine Lifescience has 6 board changes on record in total.
The registered office of Alpine Lifescience is at C – 57X3 Ground Floor C – Block Dilshad Garden Shahdara Delhi, New Delhi, Delhi, India – 110095.
Alpine Lifescience operates in the pharma industry, in the drug formulation and development segment.
Alpine Lifescience has 1 associated brand: Alpine Life Science.